CCCC
C4 Therapeutics Inc
Price:  
2.66 
USD
Volume:  
483,004.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CCCC EV/EBITDA

-1456.1%
Upside

As of 2025-09-14, the EV/EBITDA ratio of C4 Therapeutics Inc (CCCC) is -0.91. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CCCC's latest enterprise value is 111.16 mil USD. CCCC's TTM EBITDA according to its financial statements is -121.62 mil USD. Dividing these 2 quantities gives us the above CCCC EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 14.1x - 17.4x 15.7x
Forward P/E multiples 22.6x - 32.7x 27.8x
Fair Price (37.59) - (28.60) (36.07)
Upside -1513.2% - -1175.3% -1456.1%
2.66 USD
Stock Price
(36.07) USD
Fair Price

CCCC EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-09-11 -0.95
2025-09-10 -0.90
2025-09-09 -0.93
2025-09-08 -0.94
2025-09-05 -0.95
2025-09-04 -0.92
2025-09-03 -0.86
2025-09-02 -0.83
2025-08-29 -0.88
2025-08-28 -0.85
2025-08-27 -0.87
2025-08-26 -0.86
2025-08-25 -0.84
2025-08-22 -0.88
2025-08-21 -0.88
2025-08-20 -0.88
2025-08-19 -0.97
2025-08-18 -1.03
2025-08-15 -0.80
2025-08-14 -0.73
2025-08-13 -0.72
2025-08-12 -0.67
2025-08-11 -0.77
2025-08-08 -0.82
2025-08-07 -0.87
2025-08-06 -0.50
2025-08-05 -0.53
2025-08-04 -0.59
2025-08-01 -0.60
2025-07-31 -0.56
2025-07-30 -0.62
2025-07-29 -0.67
2025-07-28 -0.63
2025-07-25 -0.68
2025-07-24 -0.70
2025-07-23 -0.77
2025-07-22 -0.66
2025-07-21 -0.69
2025-07-18 -0.71
2025-07-17 -0.63
2025-07-16 -0.54
2025-07-15 -0.59
2025-07-14 -0.75
2025-07-11 -0.66
2025-07-10 -0.52
2025-07-09 -0.54
2025-07-08 -0.36
2025-07-07 -0.25
2025-07-03 -0.22
2025-07-02 -0.25